AbbVie (ABBV) Market Capitalization (2012 - 2026)

AbbVie (ABBV) has reported Market Capitalization for 15 consecutive years, with $444.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 35.61% year-over-year to $444.7 billion in Q2 2026; TTM through Jun 2026 was $444.7 billion, a 35.61% increase from a year earlier, with the FY2025 full-year figure at $404.0 billion, up 28.79% from the prior year.
• Market Capitalization was $444.7 billion for Q2 2026 at AbbVie, up from $384.3 billion in the prior quarter.
• Over five years, Market Capitalization peaked at $444.7 billion in Q2 2026 and troughed at $237.3 billion in Q3 2022.
• A 5-year average of $320.2 billion and a median of $308.3 billion in 2024 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization surged 49.87% in 2022 and dropped 12.18% in 2023, its largest moves.
• Over 5 years, Market Capitalization stood at $286.0 billion in 2022, then declined by 4.27% to $273.8 billion in 2023, then advanced by 14.59% to $313.7 billion in 2024, then gained by 28.79% to $404.0 billion in 2025, then grew by 10.07% to $444.7 billion in 2026.
• The last three Market Capitalization figures came in at $444.7 billion (Q2 2026), $384.3 billion (Q1 2026), and $404.0 billion (Q4 2025), per Business Quant data.